12 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18742011 | HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR PURIFICATION OF OLIGONUCLEOTIDES | GALSTER, SAMUEL LEONARD | 1693 | Final Rejection | Jun 13, 2024 |
| 18385674 | IMPLANTABLE CRANIAL MEDICAL DEVICE | PATEL, SHEFALI DILIP | 3783 | Non-Final OA | Oct 31, 2023 |
| 18285123 | COMBINATION TREATMENT METHODS OF MULTIPLE SCLEROSIS | WEDDINGTON, KEVIN E | 1629 | Non-Final OA | Sep 29, 2023 |
| 18283614 | REDUCING HOST CELL IMPURITIES DURING RECOMBINANT PROTEIN PRODUCTION | HOLLAND, PAUL J | 1656 | Non-Final OA | Sep 22, 2023 |
| 18269073 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE | ROMERO, KRISTEN WANG | 1624 | Non-Final OA | Jun 22, 2023 |
| 18269086 | 2H-INDAZOLE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE | REILLY, SOPHIA JANE | 1627 | Non-Final OA | Jun 22, 2023 |
| 18036853 | PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | May 12, 2023 |
| 18036620 | BIPHASIC SUBCUTANEOUS DOSING REGIMENS FOR ANTI-VLA-4 ANTIBODIES | MIDDLETON, DANAYA L | 1674 | Non-Final OA | May 11, 2023 |
| 18021643 | METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS | CORNET, JEAN P | 1628 | Final Rejection | Feb 16, 2023 |
| 17904802 | COGNITIVE SCREENING METHODS | ALSOMAIRY, SELWA ABDO | 3715 | Non-Final OA | Aug 23, 2022 |
| 17635363 | COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY | MCKILLOP, JOHN CHARLES | 1637 | Non-Final OA | Feb 14, 2022 |
| 17380694 | MONITORING BASED ON CONTINUOUS INTRACRANIAL EEG ACTIVITY | SHOSTAK, ANDREY | 3791 | Final Rejection | Jul 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial